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AbstrACt
Objective To estimate the cost implications of early 
angiography for patients with suspected non-ST elevation 
acute coronary syndrome (NSTEACS) using tissue Doppler 
imaging (TDI).
Design A decision tree model was used to synthesise 
data from the pilot study and literature sources. Sensitivity 
analyses tested the impact of assumptions incorporated 
into the analysis.
setting Emergency department (ED), Brisbane, Australia.
Participants Patients with suspected NSTEACS.
Interventions TDI as a diagnostic tool for triaging patients 
within 4 hours of presentation in addition to conventional 
risk stratiication, compared with conventional risk 
stratiication alone.
Data sources Resource used for diagnosis and 
management were recorded prospectively and costed 
for 51 adults who had echocardiography within 24 hours 
of admission. Costs for conventional care were based on 
observed data. Cost estimates for the TDI intervention 
assumed patients classiied as high risk at TDI (E/e’>14) 
progressed early to angiography with an associated 1-day 
reduction in length of stay.
Primary outcome measures Costs until discharge from 
the Australian healthcare perspective in 2016–2017 
prices.
results Findings suggest that using TDI as a diagnostic 
tool for triaging patients with suspected NSTEACS is likely 
to be cost saving by $A1090 (95% credible interval: $A573 
to $A1703) per patient compared with conventional care. 
The results are mainly driven by the assumed reduction in 
length of stay due to the inclusion of early TDI in clinical 
decision-making.
Conclusions This pilot study indicates that compared 
with conventional risk stratiication, triaging patients 
presenting with suspected NSTEACS with TDI within 
4 hours of ED presentation has potential cost savings. 
Findings assume a reduction in hospital stay is achieved 
for patients considered to be high risk at TDI. Larger, 
comparative studies with longer follow-up are needed to 
conirm the clinical effectiveness of TDI as a diagnostic 
strategy for NSTEACS, the assumed reduction in hospital 
stay and any cost saving.
IntrODuCtIOn
Acute coronary syndrome (ACS) is a signif-
icant contributor to both morbidity and 
mortality globally, accounting for almost half 
of all deaths related to cardiovascular disease.1 
It comprises a broad spectrum of clinical 
presentations including ST-elevated ACS and 
non-ST elevated ACS (NSTEACS). In devel-
oped economies, incident rates of ACS are 
declining but they remain one of the main 
contributors of premature death in adults.2 
Suspected ACS represents a substantial finan-
cial burden to the healthcare system as 20% 
of patients are rehospitalised within 6 months 
of their initial admission.3 In Australia, ACS 
strengths and limitations of this study
 Ź The economic evaluation used evidence on health-
care resource use and probabilities prospectively 
obtained alongside a pragmatic pilot study to assess 
the prognostic utility of tissue Doppler imaging (TDI) 
in patients with suspected non-ST elevation acute 
coronary syndrome.
 Ź The analysis was based on data from a non-com-
parative pilot study, and assumed a hypothetical 
(rather than observed) reduction in hospital length 
of stay would result from early progression to an-
giography in patients classiied as ‘high risk’ if TDI 
was performed within 4 hours of hospital admission.
 Ź The decision-analytical model assumes equal clini-
cal outcome regardless of triaging strategy and did 
not include potential long-term outcomes, for exam-
ple, survival and quality of life.
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accounts for 5%–10% of all emergency department 
(ED) presentations4 and is responsible for approximately 
75 000 hospital admissions and 10 000 deaths annually.5 
Over two-thirds (65%–70%) of all myocardial infarc-
tions are categorised as NSTEACS.6 Management of 
patients with a working diagnosis of NSTEACS depends 
on risk stratification.7 Early identification of low-risk 
individuals improves effectiveness of care to those in 
highest need and helps prevent unnecessary admission to 
hospital. Thus, early diagnosis of NSTEACS is expected 
to reduce the huge burden of care in terms of morbidity, 
mortality and costs.8 Previous studies in Australia indicate 
that early identification of an intermediate-risk group 
and use of an accelerated diagnostic approach such as 
the Brisbane protocol would be a cost-saving approach as 
they are associated with lower expected costs and length 
of stay (LoS).9 10 Current guidelines recommend the time 
to angiography to be less than 24 hours for ‘high risk’ 
and less than 72 hours for the remainder of patients.11 
However, the management and risk stratifications in prac-
tice remain suboptimal. In one study, only half of the 
NSTEACS patients underwent guideline-recommended 
invasive management.12
Incorporation of diagnostic tools such as tissue Doppler 
imaging (TDI) for the non-invasive evaluation of diastolic 
function in critical settings such as the ED is time effi-
cient, inexpensive and could help improve risk stratifi-
cation.13 Thus, these tools have the potential to improve 
the management of patients with suspected NSTEACS. 
The TDI parameter, that is, the ratio of early transmi-
tral flow velocity to early diastolic septal mitral annulus 
velocity (E/e’) is a powerful predictor of cardiac isch-
aemia and subsequent mortality.14 Echocardiography can 
be safely used to evaluate cardiac diastolic function at the 
bedside. The patient-important qualities favouring TDI 
are numerous and include its acceptability to the patient, 
applicability at bedside, ease of use at point of care, a 
high level of concordance between observers,15 reproduc-
ibility, validity, feasibility and prognostic utility.16
The purpose of this cost-minimisation analysis was to 
evaluate the cost implications of TDI-guided (E/e’>14) 
risk stratification of suspected NSTEACS patients from 
‘low or intermediate risk’ to ‘high risk’ and early angiog-
raphy (within 4 hours of presentation at ED) compared 
with standard (usual) care. The National Emergency 
Access Target stipulates that a predetermined proportion 
of patients should be admitted, discharged or transferred 
from the ED within 4 hours of presentation.17 Thus, the 
4 hours benchmark is compatible with current guidelines 
to pursue definitive reperfusion within 8–12 hours of 
onset of ischaemic pain.
MethODs
A cost-minimisation decision analysis was undertaken 
from the healthcare perspective, to compare the costs of 
utilising TDI within 4 hours of ED presentation in addi-
tion to conventional risk stratification as a triaging tool 
for subsequent angiography for adults with suspected 
NSTEACS, compared with conventional risk stratifica-
tion alone. Data for the decision-analytical model were 
primarily obtained from an Australian cohort study (the 
Tissue Doppler Evaluation of Diastolic Dysfunction in 
Emergency Department Non-ST Elevation Acute Coro-
nary Syndromes (TEDDy-NSTEACS) study). Our study 
was undertaken accordingly to the Consolidated Health 
Economic Evaluation Reporting Standards (CHEERS) 
guidelines of reporting health economic evaluations.18
the teDDy-nsteACs study
The TEDDy-NSTEACS study was a prospective cohort 
study conducted at the Mater Hospital Brisbane between 
August 2014 and October 2015. Adults (≥18 years) 
presenting to the ED with chest pain and admitted to the 
coronary care unit (CCU) for further diagnostic, prog-
nostic and acute management of suspected NSTEACS 
were approached for enrolment in this observational 
cohort study. Patients enrolled in the study had an echo-
cardiography within 24 hours of admission in addition 
to standard of care and an E/e’ was calculated. As this 
was an observational cohort study, comparative clinical 
outcomes were not investigated for different triaging 
strategies. However, since the intent of triaging with TDI 
in addition to conventional risk stratification is to reach 
a quicker diagnosis, this economic evaluation assumes 
equivalent clinical outcomes regardless of triaging 
strategy. We consider this to be a conservative assump-
tion. Therefore, a cost-minimisation approach is applied.
The primary prognostic variables of interest for the 
related prognostic study were mean E/e’ and serum 
biopeptide N-Terminus B-type natriuretic peptide 
(NT-proBNP). We hypothesise that TDI performed at 
the point of care in ED patients admitted for chest pain 
and suspected of NSTEACS may reduce expenditure by 
improving the accuracy of triage and reducing resource 
utilisation. Use of echocardiography to more accurately 
predict patients who are at a higher risk of an NSTEACS 
compared with conventional triaging may be cost-effec-
tive. Our data demonstrated NT-proBNP to be inferior to 
TDI in risk stratification of NSTEACS. It is not considered 
in this economic evaluation because our clinical data do 
not support its translation to clinical use for this purpose.
Diagnostic strategies
The patients presenting at the ED with chest pain in the 
cohort study were triaged using conventional risk strat-
ification and management using American College of 
Cardiology and American Heart Foundation .19 Thus, we 
first measured the resource utilisation and estimated the 
cost of standard (usual) care for managing and treating 
patients with suspected NSTEACS from ED presentation 
to hospital discharge. The resource utilisation for the 
observational cohort was used for the comparator arm in 
the decision-analytical model.
The intervention of interest for the model was the 
application of TDI within 4 hours of presentation to ED 
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as a triaging tool, to guide management. In addition to 
the conventional risk stratification for patients suspected 
of NSTEACS, TDI was performed during the admis-
sion. The E/e’ was measured to evaluate the prognostic 
utility of TDI in patients with suspected NSTEACS using 
a threshold of mean E/e’>14 based on the most recent 
recommendations by the American Society of Echocardi-
ography and European Association of Cardiac Imaging.20
Although E/e’ was measured in the cohort study, it was 
not used in clinical decision-making in the study. Thus, 
we estimated the short-term costs from admission to 
discharge of a hypothetical diagnostic strategy involving 
TDI within 4 hours of admission, based on clinical judge-
ment of two authors (MA and DJS) what would have been 
assumed to occur to patients, should the TDI results have 
been acted on. In the TDI strategy, patients with E/e’>14 
were considered high risk, and were assumed to progress 
directly to angiogram for diagnosis. Diagnostic parame-
ters (sensitivity and specificity) performed early during 
initial hospitalisation as compared with the gold-standard 
angiogram for diagnosing NSTEACS were used. When 
TDI was used as a diagnostic tool for non-ST elevation 
myocardial infarction (NSTEMI) compared with angio-
gram as gold standard, the specificity of E/e’>14 to detect 
NSTEMI was 86% (95% CI 0.72% to 0.95%) and sensi-
tivity of 67% (95% CI 0.30% to 0.93%).
In patients with coronary disease, a review of the liter-
ature on diastolic dysfunction concluded that the evalua-
tion of diastolic dysfunction has diagnostic and prognostic 
roles in the management of ACS.21 22 TDI in the form of 
E/e’ has emerged as a superior predictor of survival after 
first acute myocardial infarction relative to other clinical 
or echocardiographic features.14 23 TDI has proven incre-
mental prognostic value with respect to routine clinical, 
laboratory and imaging information.24 25 The predictive 
power of E/e’ has been recently confirmed in patients 
that underwent coronary angiography after their first 
ever NSTEMI.26
The analysis was conducted in two parts. The first 
analysis involved costing of resource utilisation for the 
cohort of 51 patients included in the pilot study to indi-
cate the costs of conventional triaging. Subsequently, we 
performed a cost-minimisation analysis to compare the 
costs of the hypothetical TDI triaging intervention to that 
of conventional triaging.
resource use
Data describing in-hospital resource utilisation related 
to the diagnosis and management of ACS episodes were 
captured with urgency-related group (URG) and diagnos-
tic-related group (DRG) codes, and electronic medical 
chart review. Resources such as diagnostic tests (echo-
cardiography scan, echocardiogram, dobutamine stress 
echocardiogram, stress test and coronary angiography), 
staff time (echocardiographer and echocardiologist), 
hospital transfers, high care and LoS from admission 
to discharge were extracted from the discharge summa-
ries and pathology databases. Costings for the ED and 
inpatient episodes were based on the assigned URG and 
DRG price weights,27 respectively. The cost of ED visit was 
calculated by multiplying the base payment (national effi-
cient price) by the relative weight of each URG while the 
cost of an inpatient episode was calculated using the base 
payment, the relative weight of each DRG, LoS and an 
intensive care unit adjustment, reflecting the increased 
cost of time spent in the CCU). Costs of diagnostic tests 
were sourced from the Medicare Benefits Schedule.28 
Thus, the total cost per patient refers to an average cost 
of hospital stay, procedures and resource use from admis-
sion to discharge. Resources used and their unit costs in 
Australian dollars at 2016 values along with sources are 
presented in table 1.
Model overview
A decision-analytical model was developed in Microsoft 
Excel, consistent with the standard treatment pathways 
Table 1 Unit costs
Cost item Unit cost ($A) Source
CT pulmonary angiography 510.00 MBS 2016,28 code 57 350
Coronary CT angiography 700.00 MBS 2016,28 code 57 360
Dobutamine stress echocardiogram 261.65 MBS 2016,28 code 55 117
Echocardiography with E/e’ measurement 53.79 Echocardiographer’s hourly rate (employee 
payscale)33
Echocardiography without E/e’ measurement 34.06 Mater Hospital data, assumed 45 min
ECG 31.25 MBS 2016,28 code 11 700
Exercise stress test echography 261.65 MBS 2016,28 code 55 116
Exercise stress test ECG 152.15 MBS 2016,28 code 11 712
Hospital transfer 671.00 Queensland Health34
Invasive angiogram 354.90 MBS 2016,28 code 38 215
MBS, Medicare Beneits Schedule.
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for patients with suspected NSTEACS, to compare the 
costs of proceeding to early angiography for patients 
with E/e’>14, compared with standard care. The deci-
sion tree (figure 1) consisted of TDI and standard care 
arms leading up to hospital discharge with a diagnosis 
of NSTEACS or ‘other than NSTEACS’, assuming equal 
long-term outcomes. For the TDI (intervention) arm, it 
was assumed that E/e’ was measured and used in clin-
ical decision-making. The cut-off value for the length of 
time from admission to receiving an echocardiography/
angiography was set to 4 hours. Previous studies evalu-
ating the early implementation of angiography in the ED 
for the evaluation of ACS indicated a reduction in LoS 
up to 1 day.29 30 In this study, we assumed patients with 
E/e’>14 were high risk and proceeded to angiography 
within 4 hours of admission, received early treatment and 
therefore earlier hospital discharge (by 1 day) than the 
standard care arm (table 2). It was assumed that high-
risk patients who had angiography within 4 hours of 
angiography but had a diagnosis other than NSTEACS 
would have the same benefit in LoS saving of 1 day, which 
is associated with quicker diagnosis. However, in the 
TEDDy-NSTEACS study patients had echocardiography 
within 24 hours of admission. Patients with E/e’≤14 were 
assumed to receive angiography with the probability and 
timings observed within the pilot study.
For the standard care arm, it was assumed that E/e’ was 
not measured, and that all patients proceed to angiog-
raphy with the probability and timings observed within 
the pilot study (table 2). All costs and time duration from 
admission to receiving echocardiography and LoS from 
admission to discharge were derived from the cohort of 
51 patients. Decision tree probabilities were derived by 
analysing data from the cohort of 51 patients. These are 
the mean values. Likewise, unit costs of echocardiography, 
angiography and ED admission were mean costs. The cost 
of hospital stay (inpatient) was estimated using weighted 
average of price weights of 15 DRG codes observed in the 
cohort study and the costing used the Australian National 
Weighted Activity Units and AR-DRG prices (2016–17).27 
The average cost per patient was estimated by multiplying 
the proportion of patients in different branches of the 
diagram (figure 1) with the unit costs of the different 
diagnostic tests, LoS, and hospitalisation. No discounting 
was applied to costs due to the short time horizon (from 
hospital admission to discharge).
sensitivity analysis
Probabilistic sensitivity analysis using 1000 Monte Carlo 
simulations was used to account for parameter uncertainty 
in model inputs. One-way deterministic sensitivity analysis 
was performed to assess the influence of various param-
eters on the model results where input parameters (95% 
lower and upper values) were varied one at a time and 
the remaining values were held at their baseline value. 
In the base-case analysis, it was assumed that patients 
who proceeded to TDI within 4 hours of admission had 
discharge 1 day earlier compared with the standard care 
arm. We also tested other plausible values (none, half and 
2 days reduction in LoS) in the scenario analyses.
Patient public involvement
No patients were involved in the development of the 
research question or the outcome measures nor the 
design of the study. There are no plans to disseminate the 
results of the research to study participants.
results
Descriptive characteristics of the participants are listed 
in table 3. During the study period, 2491 patients with 
chest pain presented to the Mater Hospital ED. Of those, 
Figure 1 Decision tree for suspected NSTEACS patients. Dx NSTEACS, diagnosis of NSTEACS; Dx other, diagnosis of other 
than NSTEACS; NSTEACS: non-ST elevation acute coronary syndrome.
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260 were admitted to the CCU for further evaluation of 
potential ACS. There were 167 participants suspected of 
NSTEACS admitted to CCU, of which 51 met inclusion 
criteria and enrolled in the study.
Table 3 details the average resource use and costs per 
patient in the pilot study by E/e’ ratio. The mean age in 
this observational cohort of 51 adults was 61 years (range 
37–87 years). The mean LoS from ED admission to 
discharge from the hospital (n=51) was 2.33 (95% CI 1.76 
to 2.90) days, and patients with E/e’>14 had a mean of 
1.04 days (95% CI −0.29 to 2.36) more LoS as compared 
with those with E/e’≤14 (ie, without the TDI result being 
acted on). The overall mean cost for the pilot study 
amounted to $A 15 573 per patient. As expected given the 
1 day longer average LoS, the mean total cost for the high 
risk patients (E/e’>14) was higher ($A 18 038) than for 
low risk (E/e’≤14) patients ($A 14 814). The preliminary 
outcome data does suggest that E/e’>14 is concerning for 
adverse outcome and E/e’≤14 reassuring for improved 
outcome.
The comparative total costs and associated uncertainty 
from the base-case and sensitivity analyses comparing TDI 
and standard care are presented in table 4. In the base-
case analysis which assumes acting on TDI is associated 
with a 1 day reduction in LoS in those with E/e’>14, the 
TDI triaging strategy was expected to cost $A1090 (95% 
credible interval (CrI): $A573 to $A1703) less per patient 
than standard care. Reducing the assumed LoS by a 
further day (to assume a 2 day reduction in LoS in those 
with E/e’>14), increases the cost savings estimated for the 
TDI strategy to $A 2293 (95% CrI: $A 1252 to $A 3553).
Threshold analysis comparing the cost difference 
between 0 and 2 days reduction in LoS suggests (figure 2) 
that the results are robust to uncertainty in all model 
parameters. As expected, when no reduction in hospital 
days is assumed, the TDI strategy was not cost saving, but 
Table 2 Parameters used to estimate diagnosis and treatment pathways
Variables Mean 95% CI Distribution Source
Prevalence of NSTEACS 0.18 0.08 to 0.31 Beta (9, 42) TEDDy-NSTEACS
Prevalence of high-risk patients (E/e’>14) 0.24 0.12 to 0.36 Beta (12, 39) TEDDy-NSTEACS
Sensitivity of TDI (for NSTEACS) 0.67 0.30 to 0.93 Beta (6, 3) TEDDy-NSTEACS
Speciicity of TDI (for NSTEACS) 0.86 0.72 to 0.95 Beta (36, 6) TEDDy-NSTEACS
Probability of angiography for patients with E/e’≤14 0.46 0.30 to 0.63 Beta (18, 21) TEDDy-NSTEACS
Angiography conirmed NSTEACS in low-risk 
patients
0.17 0.12 to 0.23 Beta (3, 15) TEDDy-NSTEACS
Proportion of low-risk patients with other diagnosis 
who did not have angiography
1.0 0.84 to 1.0 Beta (21, 0) TEDDy-NSTEACS
Probability of angiography in standard care 0.41 0.28 to 0.56 Beta (21, 30) TEDDy-NSTEACS
Prevalence of NSTEACS conirmed by angiography 0.29 0.11 to 0.52 Beta (6, 15) TEDDy-NSTEACS
Proportion of patients with other diagnosis who 
did not have angiography
0.90 0.74 to 0.98 Beta (27, 3) TEDDy-NSTEACS
Cost of angiography* $A524.96 $A450.39 to 
$A599.52
Gamma (215, 2) MBS 201628
Mean LoS from CCU admission to discharge (days) 2.24 1.67 to 2.81 lognormal (0.8, 
0.13)
TEDDy-NSTEACS
Reduction in hospital days associated with early 
angiography if TDI performed within 4 hours of 
admission indicates E/e’>14
1 varied 0 to 2 days 
in sensitivity 
analysis
Fixed Assumption for TDI 
arm
Cost of echocardiographer’s time (per hour) $A 53.79 $A43.25 to 
$A64.33
Gamma (100, 
0.54)
Mater Hospital data
Cost of ED visit† $A 976 $A958 to $A994 Gamma (12298, 
0.1)
NEP 2016–1727
Price weight for acute admitted patients‡ 0.77 – Fixed NEP 2016–1727
LoS and cost data for standard care arm were based on audit data of 51 patient. 
*Weighted average of CTCA (n=9), CTPA (n=3) and invasive angiography (n=9).
†Weighted average of price weights of 5 URG V.1.4 codes: 16, 24, 27, 29 and 86.
‡Weighted average of price weights of 15 DRG V.8.0 codes: E61B, F10A, F10B, F14B, F15B, F41A, F41B, F42B, F60A, F69B, F72B, F74A, 
F74B, F76A and G67B.
CCU, coronary care unit; CTCA, CT coronary angiography; CTPA, CT pulmonary angiography; DRG, diagnostic-related group; ED, emergency 
department; LoS, length of stay; NEP, National Eficient Price Determination; NSTEACS; non-ST elevation acute coronary syndrome; TDI, 
tissue Doppler imaging; TEDDy-NSTEACS;  Tissue Doppler Evaluation of Diastolic Dysfunction in Emergency Department Non-ST Elevation 
Acute Coronary Syndromes; URG, urgency-related group.
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rather was estimated to cost $A113 (95% CrI: $A10 to 
$A214) per patient more than standard care.
The one-way deterministic sensitivity analyses (figure 3) 
indicate that the base-case point estimate is most sensi-
tive to changes in prevalence of the high-risk group 
(E/e’>14), the probability of other diagnosis in low-risk 
group (E/e’≤14) who did not have angiography, preva-
lence of angiography in the cohort, and costs associated 
with angiography and echocardiography. The base-case 
cost saving was not very sensitive to the sensitivity and 
specificity of TDI.
DIsCussIOn
summary of indings
Our findings provide support for the hypothesis that 
triaging patients presenting with suspected NSTEACS 
to have an angiography based on TDI within 4 hours of 
presentation at the ED in addition to conventional risk 
stratification is likely to be a cost-saving intervention. This 
is promising but the large CI around the point estimate 
highlights uncertainty in the results and the small sample 
size in the cohort study whose data underpin the model. 
Moreover, as the TEDDy-NSTEACS was a pilot study 
without an observed comparator, the data underpinning 
the model were based on assumptions around key vari-
ables (in particular, LoS). Nevertheless, the TDI strategy 
was cost saving under plausible assumptions tested in the 
model. Originally, an economic evaluation was proposed 
alongside this cohort study with the expectation that the 
proposed TDI intervention would rule out patients who 
tested negative for NSTEACS according to the angio-
gram, thus allowing their early discharge. However, the 
clinical study showed that this diagnostic tool is partic-
ularly robust in detecting major adverse cardiac event 
(MACE) but less robust in detecting negative predictive 
values.
This is consistent with prior studies that have indi-
cated the threshold of 14 for E/e’ is highly specific 
Table 3 Patient characteristics and summary of resource use and costs by E/e’ in TEDDy-NSTEACS cohort study
Variables E/e’≤14 (n=39) mean (SD) E/e’>14 (n=12)mean (SD) Total (n=51) mean (SD)
Patient characteristics
  Age in years, mean (range) 57 (37–82) 75 (63–87) 61 (37–87)
  Male, n (%) 19 (49) 1 (8) 20 (39)
  Hypertension, n (%) 30 (77) 11 (92) 41 (80)
  Hyperlipidaemia, n (%) 25 (64) 11 (92) 36 (71)
  Diabetes, n (%) 7 (18) 5 (42) 12 (24)
  Prior CABG, n (%) 1 (3) 4 (33) 5 (10)
  CKD, n (%) 3 (8) 3 (25) 6 (12)
  Prior MI, n (%) 3 (8) 2 (17) 5 (10)
  TIMI Score>2, n (%) 12 (31) 10 (83) 22 (43)
  NT-proBNP, mean (range) 387 (6–6045) 2027 (112–8098) 787 (6–8098)
  E/e’, mean (range) 9.09 (5.4–13.1) 19.4 (14.6–24) 11.5 (5.9–24)
  E’, mean (range) 7.7 (4.5–10.4) 5.1 (2.5–7.4) 7.1 (2.5–10.4)
Resource use
  LoS in ED (in hours) 1.99 (2.78) 2.62 (4.12) 2.13 (3.11)
  LoS in CCU (in days) 2.00 (1.75) 3.01 (2.69) 2.24 (2.02)
  Hospital days 2.08 (1.77) 3.12 (2.64) 2.33 (2.03)
  Time from ED admission to 
echocardiography (in hours)
14.69 (7.15) 15.01 (9.05) 14.76 (7.54)
Costs ($A)
  Cost of ED visit 984 (61) 950 (64) 976 (63)
  CCU cost 13 177 (8545) 16 391 (10 587) 13 934 (9 058)
  Cost of echocardiography scan 34.06 (12.48) 31.49 (9.16) 33.45 (11.75)
  Total cost per patient 14 814 (8825) 18 038 (10 890) 15 573 (9 338)
E/e’: ratio of early transmitral low velocity to spectral tissue peak early diastolic velocity at mitral annulus. 
e’: spectral tissue peak early diastolic velocity at mitral annulus. 
CABG, coronary artery bypass graft; CCU, coronary care unit; CKD, chronic kidney disease; ED, emergency department; ; MI, myocardial 
infarction; NT-proBNP, N-Terminal B-type natriuretic peptide; TEDDy-NSTEACS, Tissue Doppler Evaluation of Diastolic Dysfunction in 
Emergency Department Non-ST Elevation Acute Coronary Syndromes; TIMI, thrombolysis in myocardial infarction.
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for measuring left ventricular diastolic dysfunction 
(LVDD).20 Although angiography within 4 hours is desir-
able, it requires high-end equipment, sufficient expertise 
in data acquisition and image interpretation, and appro-
priate patient selection which limits broad implementa-
tion of cardiac CT in the emergency room. In order to 
stratify patients in the cohort, low or high risk, E/e’ values 
were used. However, the decision to proceed to angiog-
raphy is also based on ongoing chest pain, rising troponin 
I (TnI), heart failure, and possibly excludes patients with 
poor premorbid level of function.
Conventional management uses biomarkers of isch-
aemia (troponins), ECG and CT coronary angiography, 
to diagnose NSTEACS.19 Carefully weighing the costs and 
benefits of the addition of TDI (E/e’) to the conventional 
management may prove it to be an optimal strategy for 
the management of patients presenting with suspected 
NSTEACS. An improvement in hospital costs can be 
achieved by early accurate diagnosis and risk stratifica-
tion.22 In previous studies, patients who tested positive 
for E/e’>14 are at an elevated risk for adverse outcomes 
and thus may benefit from receiving immediate medical 
management or coronary intervention.21 If TDI improves 
patient risk stratification and prognostication and reduces 
LoS, it will likely be associated with decreased healthcare 
costs. Data are scant regarding the feasibility of using left 
ventricular diastolic function as a cost-saving risk stratifi-
cation tool for adults admitted to hospital with suspected 
NSTEACS. In patients with acute chest pain suspected of 
NSTEACS, E/e’>14 may provide additional healthcare 
Table 4 Base-case and sensitivity analyses
Cost per patient ($A)
TDI Standard care Incremental cost
Base-case analysis (LoS 
reduced by 1 day*)
15 338
(12 665 to 18 409)
16 431
(13 823 to 19 459)
−1090
(−1703 to −573)
Sensitivity analyses
  No reduction in LoS† 16 538
(13 984 to 19 602)
16 425
(13 877 to 19 505)
113
(10 to 214)
  LoS reduced by one and half 
days*
14 747
(12 067 to 18 014)
16 435
(13 849 to 19 569)
−1689
(−2589 to −919)
  LoS reduced by 2 days* 14 165
(11 272 to 17 439)
16 458
(13 838 to 19 580)
−2293
(−3553 to −1252)
Values are mean and 95% credible interval.
*Reduction in hospital LoS from progression to early angiography, which is assumed to occur for those in whom TDI within 4 hours of 
admission indicates E/e’>14.
†The mean costs in the table for TDI and standard care, when no reduction in LoS is assumed, are close to but not exactly equal due to the 
bootstrapping method and rounding error.
LoS, length of stay; TDI, tissue Doppler imaging.
Figure 2 Probabilistic sensitivity analysis: variation of the 
reduction in length of stay (LoS) with TDI (range 0–48 hours) 
and the impact on the incremental cost (TDI vs standard 
care). Point estimates are mean costs in 2016–2017 
Australian dollars. Vertical lines refer to variability in point 
estimates, that is, 95% credible intervals around incremental 
cost ($A). TDI, tissue Doppler imaging.
Figure 3 Tornado diagram showing a series of one-way 
sensitivity analyses comparing standard care with TDI. The 
vertical line represents the base-case cost savings ($A1090) 
and the tails of each bar indicate the changes in cost savings 
when individual parameter values are varied. NSTEACS, non-
ST elevation acute coronary syndrome; TDI, tissue Doppler 
imaging.
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cost saving over and above current clinical, biochemical 
parameters, risk scores, that are regularly performed. 
This pilot study supports early measurement of LVDD in 
acute chest pain management.
strengths and limitations
This analysis is indicative only. It is based on a single cohort 
pilot study with relatively small sample size (n=51) with 
no direct comparative data; consequently, the economic 
analysis is based on a relatively simple decision model. 
The intervention is hypothetical and the model assumes 
a 1-day reduction in LoS for patients with E/e’>14 due to 
efficiencies with triaging assumed to result from TDI.29 30 
Direct costs related to the intervention and standard care 
were collected but could not be complemented by micro-
costing data. Assumptions made for the intervention arm 
(eg, in reduction of hospital stay days) were arbitrary. If 
the prevalences of E/e’>14 or LoS reductions associated 
with the intervention were higher than assumed in the 
model, then the model would tend to underestimate any 
cost savings associated with the intervention, and vice 
versa. A larger, comparative study would strengthen the 
evidence of TDI cost-effectiveness, as well as confirming 
the clinical place of TDI in triaging patients with suspected 
NSTEACS.
Our model did not include potential long-term 
outcomes, for example, survival and quality of life; instead, 
it assumes equal clinical outcome regardless of triaging 
strategy. Evidence to support this assumption stems from 
prior research which has demonstrated the strong predic-
tive power of E/e’ for myocardial infarction, MACE and 
all-cause mortality.21–23 25 31 32 However, our model results 
are dominated by the short-term costs of diagnostic tests 
and treatment rather than by long-term outcomes. It is 
possible that long-term consequences of implementing 
TDI within 4 hours of presentation at ED in patients 
with suspected NSTEACS exist. Thus, the findings of this 
economic evaluation suggest TDI triaging in the ED is a 
promising strategy that warrants further investigation to 
confirm associated clinical and economic outcomes.
COnClusIOns
Based on data from a pilot cohort study, this economic 
analysis indicates that the addition of TDI to the conven-
tional risk stratification approach for triaging adults with 
suspected NSTEACS in the ED has the potential to save 
healthcare costs of approximately $A1100 per patient 
between hospital admission to discharge. However, this 
study makes a number of assumptions and should be 
considered to be indicative only. Further studies are 
needed to confirm the clinical effectiveness of TDI in risk 
stratification for ACS, reduction in hospital stay and long-
term outcomes, and the resulting cost-effectiveness.
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